PeterLabs Holdings Bhd Market Cap ($16.58 Million)
Market Cap & Net Worth: PeterLabs Holdings Bhd (0171)
PeterLabs Holdings Bhd market cap. PeterLabs Holdings Bhd (KLSE:0171) has a market capitalization of $16.58 Million (RM66.05 Million) as of November 1, 2026. Listed on the KLSE stock exchange, this Malaysia-based company holds position #25557 globally and #725 in its home market, demonstrating a 6.67% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PeterLabs Holdings Bhd's stock price RM0.24 by its total outstanding shares 275213890 (275.21 Million). Also see 0171 cash flow conversion for how efficiently the company converts equity into cash flow.
PeterLabs Holdings Bhd Market Cap History (2015–2026)
PeterLabs Holdings Bhd market cap history from 2015 to 2026. Data shows growth from $16.69 Million to $16.58 Million (1.91% CAGR). Check current stock price of PeterLabs Holdings Bhd for real-time trading data and today's change.
PeterLabs Holdings Bhd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PeterLabs Holdings Bhd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore PeterLabs Holdings Bhd net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.05x
PeterLabs Holdings Bhd's market cap is 0.05 times its annual revenue
Latest Price to Earnings (P/E) Ratio
5.74x
PeterLabs Holdings Bhd's market cap is 5.74 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $16.69 Million | $73.48 Million | $3.34 Million | 0.23x | 5.00x |
| 2016 | $14.88 Million | $83.58 Million | $3.33 Million | 0.18x | 4.46x |
| 2017 | $17.98 Million | $94.73 Million | $4.01 Million | 0.19x | 4.49x |
| 2018 | $17.35 Million | $90.42 Million | $3.80 Million | 0.19x | 4.57x |
| 2019 | $12.93 Million | $96.23 Million | $4.28 Million | 0.13x | 3.03x |
| 2020 | $15.44 Million | $80.03 Million | $3.89 Million | 0.19x | 3.97x |
| 2021 | $14.46 Million | $183.82 Million | $5.48 Million | 0.08x | 2.64x |
| 2022 | $13.21 Million | $161.63 Million | $3.60 Million | 0.08x | 3.67x |
| 2023 | $14.23 Million | $186.21 Million | $1.39 Million | 0.08x | 10.27x |
| 2024 | $13.13 Million | $242.21 Million | $2.29 Million | 0.05x | 5.74x |
Competitor Companies of 0171 by Market Capitalization
Companies near PeterLabs Holdings Bhd in the global market cap rankings as of November 1, 2026. Also see PeterLabs Holdings Bhd asset portfolio for a full breakdown of the balance sheet.
Key companies related to PeterLabs Holdings Bhd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #535 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #593 globally with a market cap of $45.23 Billion USD ( CN¥309.13 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #535 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.62 |
| #593 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.23 Billion | CN¥48.46 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.30 |
Market Capitalization of PeterLabs Holdings Bhd (2015–2026)
Market capitalization of PeterLabs Holdings Bhd from 2015 to today. Between 2015 and today, PeterLabs Holdings Bhd's market cap moved from $16.69 Million to $ 16.58 Million, with a yearly change of 1.91%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | RM16.58 Million | -2.04% |
| 2025 | RM16.93 Million | +28.95% |
| 2024 | RM13.13 Million | -7.72% |
| 2023 | RM14.23 Million | +7.69% |
| 2022 | RM13.21 Million | -8.60% |
| 2021 | RM14.46 Million | -6.40% |
| 2020 | RM15.44 Million | +19.39% |
| 2019 | RM12.93 Million | -25.45% |
| 2018 | RM17.35 Million | -3.50% |
| 2017 | RM17.98 Million | +20.85% |
| 2016 | RM14.88 Million | -10.85% |
| 2015 | RM16.69 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of PeterLabs Holdings Bhd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $16.58 Million USD |
| MoneyControl | $16.58 Million USD |
| MarketWatch | $16.58 Million USD |
| marketcap.company | $16.58 Million USD |
| Reuters | $16.58 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About PeterLabs Holdings Bhd
PeterLabs Holdings Berhad, an investment holding company, engages in manufacturing, distribution, trading, and export of animal health and nutrition products in Malaysia and internationally. The company operates through three segments: Manufacturing, Trading, and Others. It offers biosecurity products and disinfectants, compound feed supplements, feed additives, nutritional premixes, pharmaceutic… Read more